Pfizer Beats the Street
July 29, 2014 at 07:52 AM EDT
After abandoning its bid for rival AstraZeneca, Pfizer posted higher-than-expected revenue boosted by cancer-drug demand. Merck Beats Forecasts
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.